During the past decade, NZOZ Centrum Medyczne conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "NZOZ Centrum Medyczne" are "Osteoarthritis" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "NZOZ Centrum Medyczne" in a lesser frequency.

Most popular intervention types in "NZOZ Centrum Medyczne" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "belimumab" (1 trials), "oxycodone" (1 trials), "placebo" (1 trials), "tanezumab 10 mg" (1 trials) and "tanezumab 5 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZOZ Centrum Medyczne" are 2 trials for "All" genders.

Currently, there are NaN active trials in "NZOZ Centrum Medyczne". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in NZOZ Centrum Medyczne, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in NZOZ Centrum Medyczne, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".